Nuvectis Pharma (NVCT) Cash from Operations (2021 - 2026)
Nuvectis Pharma (NVCT) reported Cash from Operations of 6511000.0 for Q1 2026, down 55.99% on a YoY basis from 14794182.91 in Q1 2025, and down 63.84% sequentially from 3974000.0 in Q4 2025.
Nuvectis Pharma (NVCT) Cash from Operations (2021 - 2026) Analysis & Trends
Nuvectis Pharma (NVCT) has 6 years of Cash from Operations data on file, last reported at 6511000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 55.99% year-over-year to 6511000.0; the trailing twelve-month figure through Mar 2026 stood at 18346000.0 (down 52.08% YoY), and the FY2025 full-year result was 16009000.0, down 30.72% from the prior year.
- Cash from Operations slipped to 6511000.0 in Q1 2026, from 3974000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2404000.0 in Q3 2024 to a low of 6511000.0 in Q1 2026.
- A 5-year average of 3781176.47 and a median of 3850000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 229.52% in 2022 and jumped 35.97% in 2024, its largest moves.
- Tracing NVCT's Cash from Operations over 5 years: stood at 3516000.0 in 2022, then decreased by 9.5% to 3850000.0 in 2023, then surged by 35.97% to 2465000.0 in 2024, then slumped by 61.22% to 3974000.0 in 2025, then plunged by 63.84% to 6511000.0 in 2026.
- Business Quant data shows NVCT's Cash from Operations at 6511000.0 in Q1 2026, 3974000.0 in Q4 2025, and 4494000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Nuvectis Pharma | 471.80 Mn | 471.80 Mn | - | -6.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.51 Mn |
| Mar 31, 2026 | -6.51 Mn |
| Dec 31, 2025 | -3.97 Mn |
| Dec 31, 2025 | -3.97 Mn |
| Sep 30, 2025 | -4.49 Mn |
| Sep 30, 2025 | -4.49 Mn |
| Jun 30, 2025 | -3.37 Mn |
| Jun 30, 2025 | -3.37 Mn |
| Mar 31, 2025 | -4.17 Mn |
| Mar 31, 2025 | -4.17 Mn |
| Dec 31, 2024 | -2.47 Mn |
| Dec 31, 2024 | -2.47 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Mar 31, 2024 | -4.36 Mn |
| Mar 31, 2024 | -4.36 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Dec 31, 2023 | -3.85 Mn |